Lactulose Zentiva

Lactulose, the active ingredient in Lactulose Zentiva, is an osmotic laxative presented as an oral solution for oral use. It is used to soften stool and promote bowel movements in patients with constipation and to reduce ammonia absorption in individuals with hepatic encephalopathy. GNH USA supplies Lactulose Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose Zentiva is an osmotic laxative that acts on the gastrointestinal tract to relieve constipation and lower ammonia levels in liver disease. - Constipation: softens stool and facilitates regular bowel movements. - Hepatic encephalopathy: lowers colonic ammonia production, helping to improve mental status in patients with liver dysfunction.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Diarrhea: loose, watery stools. - Nausea: sensation of wanting to vomit. - Stomach cramps: intermittent abdominal pain. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: notably low potassium or sodium levels. - Dehydration: excessive fluid loss leading to low blood volume. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent, intense pain requiring medical attention. - Hepatic decompensation: worsening liver function in susceptible patients. - Hypernatremia: elevated blood sodium concentration.

Before initiating Lactulose therapy, consider patient‑specific factors and monitor for potential complications. - Renal function assessment: evaluate kidney status, especially in patients with chronic kidney disease. - Electrolyte monitoring: check serum potassium and sodium periodically. - Diabetes caution: monitor blood glucose as lactulose may affect carbohydrate metabolism. - Concomitant laxatives: avoid using other strong laxatives to prevent excessive diarrhea. - Hepatic impairment: adjust dose based on clinical response and ammonia levels. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can influence the absorption or effectiveness of several medicines; interactions vary in clinical significance.

Major Interactions (Avoid): - Antibiotics (e.g., neomycin): may reduce lactulose efficacy by altering gut flora. - Other osmotic laxatives (e.g., magnesium hydroxide): increase risk of severe diarrhea and electrolyte loss. - Antacids containing magnesium: can potentiate laxative effect and cause dehydration.

Moderate Interactions (Monitor Closely): - Oral iron supplements: reduced iron absorption due to increased intestinal transit. - Phosphate binders: may be less effective when taken with lactulose. - Probiotic preparations: potential alteration of gut microbiota affecting lactulose metabolism. - Diabetes medications: monitor glucose as changes in bowel habits may affect glycemic control.